Opportunities & Announcements

Find NIAID grant funding opportunity announcements (FOAs) and Notices of Special Interest (NOSIs) below. Subscribe for Email Updates. Also see NIAID Contract Solicitations or Find Funding Outside NIH.

161 Results
Title Activity Code Posting Date Sort ascending Expiration Date
Understanding the Clinical History of Bacterial Sexually Transmitted Infections (STI) to Accelerate Diagnostic and Vaccine Development (R01 Clinical Trial Not Allowed)- RFA-AI-22-034 R01 May 12, 2022 September 13, 2022
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)- PAR-22-105 R01 May 10, 2022 May 08, 2025
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)- PAR-22-109 R21 May 10, 2022 May 08, 2025
Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01 Clinical Trial Not Allowed)- RFA-AI-22-037 R01 May 10, 2022 September 15, 2022
Notice of Special Interest (NOSI)—Administrative Supplements for NIAID Regional Biocontainment Laboratories (RBL) and other NIH Grantees Conducting Research at RBL-affiliated Sites- NOT-AI-22-049 Supp May 04, 2022 June 01, 2022
Understanding the Basic Mechanisms of Immune-related Adverse Events (irAEs) in Cancer Immunotherapy- NOT-CA-22-063 Multiple May 03, 2022 July 05, 2024
Notice of Special Interest (NOSI)— Sustained Release of Antivirals for Treatment or Prevention of HIV or Treatment of Latent TB/HBV (SRATP) - NOT-AI-22-042 R01 April 29, 2022 May 08, 2025
Notice of Special Interest (NOSI)—Towards Developing a Cure for HBV in HIV/HBV Co-Infection - NOT-AI-22-043 R01, R41/R42, R21, R43/R44 April 29, 2022 May 08, 2025
Notice of Special Interest (NOSI)—Administrative Supplements for Lyme Disease and other Tickborne Illnesses - NOT-AI-22-048 Supp April 27, 2022 May 24, 2022
Limited Interaction Targeted Epidemiology—Viral Suppression (LITE-VS) (UG3/UH3 Clinical Trial Optional)- RFA-AI-22-024 UG3/UH3 April 13, 2022 August 04, 2022
Small Research Grants for Analysis, Curation, and/or Sharing of Down syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed)- RFA-OD-22-008 R03 April 08, 2022 July 02, 2024
NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)- PAR-20-153 R25 April 08, 2022 July 14, 2022
Notice of Special Interest (NOSI)—Administrative Supplements for Research on Womens Health in the IDeA States- NOT-GM-22-005 Supp April 06, 2022 October 18, 2024
Development and Optimization of Next-Generation Immunological Assays to Support Influenza Clinical Studies and Trials (UH2/UH3 Clinical Trial Not Allowed)- RFA-AI-22-020 UH2/UH3 April 05, 2022 July 02, 2022
Partnerships for the Development of Novel Therapeutics to Combat Select Antibiotic Resistant Bacteria and Fungi (R01 Clinical Trial Not Allowed)- RFA-AI-22-028 R01 April 05, 2022 July 30, 2022
Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed)- RFA-OD-22-009 R01 April 05, 2022 July 02, 2024
Enhancing HIV Reservoir Susceptibility to Elimination (R01 Clinical Trial Not Allowed)- RFA-AI-22-025 R01 March 29, 2022 August 04, 2022
NIAID Research Education Program (R25 Clinical Trial Not Allowed)- PAR-22-134 R25 March 15, 2022 October 10, 2024
Limited Competition—Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)- RFA-HL-23-007 K38 March 14, 2022 January 11, 2025
Development of HIV Broadly Neutralizing Antibody Susceptibility Assays (R61/R33 Clinical Trial Not Allowed)- RFA-AI-22-022 R61/R33 March 10, 2022 August 04, 2022
International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)- PAR-22-118 R25 March 10, 2022 June 07, 2024
Notice of Special Interest (NOSI)— NIAID Administrative Supplement To Promote Discovery of Medical Countermeasures Against Chemical Threats - NOT-AI-22-030 Supp March 02, 2022 March 02, 2024
Improved Drug Susceptibility Testing (DST) for Tuberculosis (R01 Clinical Trial Not Allowed)- RFA-AI-22-016 R01 March 02, 2022 July 09, 2022
Notice of Special Interest (NOSI)—CCRP Administrative Supplement for Collaborative Science To Synergize Chemical Medical Countermeasures Discovery and Early Development - NOT-AI-22-029 Supp February 25, 2022 March 02, 2024
Immune Drivers of Autoimmune Disease (IDAD) (U01 Clinical Trial Not Allowed)- RFA-AI-22-012 U01 February 24, 2022 July 02, 2022